Test

Clinical Trial on Investigational Treatment for Migraine Relief

Recruiting
18 years - 100 years
All
Phase 1
1 Location

Brief description of study.

Test

Detailed description of study

Test

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Anxiety
  • Age: 18 years - 100 years
  • Gender: All
Updated on 19 Feb 2024. Study ID: IRB-1212
  • Who can participate: Participants aged 18 to 65 who experience frequent migraines and have not responded to standard treatments may be eligible for this study.
  • Study details: Participants will be randomly assigned to receive either the investigational treatment or a placebo. They will be required to attend regular clinic visits for monitoring and assessment of treatment effects.

Find a site

Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact label
Race
Ethnicity
Other language

Default Content Message Here